Nautilus Biotechnology (NAUT) Depreciation and Depletion (2020 - 2026)
Nautilus Biotechnology has reported Depreciation and Depletion over the past 7 years, most recently at $334000.0 for Q1 2026.
- Quarterly results put Depreciation and Depletion at $334000.0 for Q1 2026, down 28.17% from a year ago — trailing twelve months through Mar 2026 was $1.5 million (down 21.93% YoY), and the annual figure for FY2025 was $1.7 million, down 15.0%.
- Depreciation and Depletion reached $334000.0 in Q1 2026 per NAUT's latest filing, down from $400000.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $549000.0 in Q4 2023 and bottomed at $300000.0 in Q1 2022.
- Median Depreciation and Depletion over the past 5 years was $400000.0 (2023), compared with a mean of $413705.9.
- The largest annual shift saw Depreciation and Depletion surged 83.0% in 2023 before it dropped 28.17% in 2026.
- Over 5 years, Depreciation and Depletion stood at $300000.0 in 2022, then soared by 83.0% to $549000.0 in 2023, then dropped by 8.93% to $500000.0 in 2024, then dropped by 20.0% to $400000.0 in 2025, then fell by 16.5% to $334000.0 in 2026.
- Business Quant data shows Depreciation and Depletion for NAUT at $334000.0 in Q1 2026, $400000.0 in Q4 2025, and $400000.0 in Q3 2025.